Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.
When I moved for high school, I remember being in awe of my adult neighbour who woke up early and went for a run every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback